MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Change in Account Payables of -$10.0 million for Q4 2025, down 202.83% on a YoY basis from $9.7 million in Q4 2024, and down 1742.08% quarter-over-quarter from $606000.0 in Q3 2025.
MeiraGTx Holdings (MGTX) Change in Account Payables (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Change in Account Payables for 9 years, with the latest figure at -$10.0 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 202.83% year-over-year to -$10.0 million; the trailing twelve-month figure through Dec 2025 stood at -$12.3 million (down 214.67% YoY), and the FY2025 full-year result was -$12.3 million, down 214.67% from the prior year.
- Change in Account Payables for Q4 2025 stood at -$10.0 million, down from $606000.0 in the prior quarter.
- The five-year high for Change in Account Payables was $14.6 million in Q1 2023, with the low at -$10.0 million in Q4 2025.
- Historically, Change in Account Payables has averaged $891950.0 across 5 years, with a median of $539000.0 in 2024.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 770.88% — and 2023, when it slumped 256.01%.
- MeiraGTx Holdings' Change in Account Payables stood at $9.4 million in 2021, then slumped by 151.76% to -$4.9 million in 2022, then soared by 37.37% to -$3.1 million in 2023, then fell by 7.28% to -$3.3 million in 2024, then tumbled by 202.83% to -$10.0 million in 2025.
- The last three Change in Account Payables figures came in at -$10.0 million (Q4 2025), $606000.0 (Q3 2025), and $93000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -9.42 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | -9.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -9.95 Mn |
| Dec 31, 2025 | -9.95 Mn |
| Sep 30, 2025 | 606,000.00 |
| Sep 30, 2025 | 606,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -3.06 Mn |
| Mar 31, 2025 | -3.06 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Dec 31, 2024 | -3.29 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Sep 30, 2024 | 8.35 Mn |
| Jun 30, 2024 | 472,000.00 |
| Jun 30, 2024 | 472,000.00 |
| Mar 31, 2024 | 5.20 Mn |
| Mar 31, 2024 | 5.20 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Dec 31, 2023 | -3.06 Mn |
| Sep 30, 2023 | -7.68 Mn |
| Sep 30, 2023 | -7.68 Mn |